AEROSOLABGABESYSTEME

European patent · EP3325060 · In force

Register entry

Publication number: EP3325060
Application number: EP16745324
Kind: European patent with effect for Switzerland and Liechtenstein
Status: In force
Specification: Granted
Filed: Jul 19, 2016
Published: May 30, 2018
Granted: Jul 3, 2019
Protection ends at the latest: Jul 18, 2036
Next annual fee due: Jul 31, 2027
IPC classes: A61M 15/00 (2006.01)
A61M 16/00 (2006.01)
Priority: US 201562194701 P 20.07.2015
US 201562212379 P 31.08.2015
PCT application: PCT/US2016/043004 19.07.2016
PCT publication: WO2017/015303 26.01.2017
Filing language: English
Source: Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

Aug 1, 2026
Next annual fee due on
Next annual fee due on
31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
Aug 1, 2025
Next annual fee due on
Next annual fee due on
31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
Aug 1, 2022
Change
Published in Swissreg on 01.08.2022
Jul 3, 2019
Granted
Published in Swissreg on 03.07.2019

Parties

Holder

Pearl Therapeutics, Inc.

200 Cardinal Way, Redwood City, CA 94063, US

Inventor

SHERWOOD, Jill Karen

Durham, North Carolina 27703, US

LEWIS, Scott

Cambridge CB4 0DW, GB

RIEBE, Michael

Durham, North Carolina 27703, US

FERRITER, Matthew

Durham, North Carolina 27703, US

PERKINS, George, McGee

Cambridge CB4 0DW, GB

DEATON, Daniel

Durham, North Carolina 27703, US

LAMBLE, Ralph

Cottenham, Cambridge CB24 8XS, GB

HAINSWORTH, John

Cambridge CB4 0DW, GB

HAMLIN, Fred, William

Cambridge CB4 0DW, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.